Each entry names what the cited source can support—and where the inference stops.
HUB-01announcement/plannedQuantum hub
IBM and Lockheed Martin announced a Swiss quantum innovation hub at ETH Zurich, with a planned IBM Quantum System Two hosted at CSCS in Lugano; deployment is expected by the end of 2026.
This is an announced plan and timeline, not confirmation that the system is already operating. IBM says deployment is expected by end-2026; ETH says operation is expected by year-end.
HUB-02unsupported inferenceQuantum hub
The announcements prove that the CSCS System Two is already operational.
Not established by the cited announcements as of this audit snapshot. Their wording describes a planned deployment and an expected future operating date.
HUB-03unsupported inferenceQuantum hub
The announcement means this reader has an account, affiliation, or access to the new system.
Not established. The announcements describe access pathways for the Swiss ecosystem and participating organizations; they do not grant access to a particular reader. This project makes no claim of affiliation with IBM, Lockheed Martin, ETH Zurich, or CSCS.
THZ-01modelled/computational613 THz claim
A 2017 computational/theoretical study reports a prominent anesthetic-associated decrease in collective dipole modes of a tubulin model in the modeled frequency band centered near 613 THz (reported by the source as 613 ± 8 THz).
This is a computational/theoretical prediction based on modeled dipole interactions, not a direct measurement in brain tissue, living tubulin, or an observed brain oscillation. The source's ±8 THz notation describes its reported modeled frequency band; it is not a statistical uncertainty estimate or confidence interval. The authors say the biological significance of the band and its relevance to anesthetic action require further investigation.
THZ-02unsupported inference613 THz claim
The 2017 paper directly measured the modeled band around 613 THz in living brain tissue or tubulin.
The cited 2017 paper calculates normal modes in a model of interacting dipoles. It does not report a direct in-vivo measurement of the modeled frequency band.
THZ-03unsupported inference613 THz claim
The modeled 613 THz band proves a biological mechanism that causes loss of consciousness.
The computational/theoretical model does not establish causation or a consciousness mechanism. Its authors explicitly say the biological significance and relevance of the frequency shift to anesthetic action need further investigation.
RAT-01animal-study behavioral resultRat study
In a within-subject experiment, epothilone B increased average latency to loss of righting reflex (LORR) under 4% isoflurane by about +69 s after treatment in eight male Long–Evans rats (N=8; two-tailed permutation t test, p=0.0016).
The primary study used a within-subject design in eight male Long–Evans rats. LORR was used as a behavioral proxy for time to become unconscious. The reported mean LORR delay was about +69 s under 4% isoflurane (p=0.0016). The study did not measure 613 THz and does not establish a quantum-consciousness mechanism; these rat findings do not establish human outcomes and are not clinical advice.
RAT-02unsupported inferenceRat study
The 2024 rat result measures the 613 THz band or establishes a quantum-consciousness mechanism.
The study measured latency to LORR as a behavioral proxy, not the modeled frequency band. It does not establish a quantum-consciousness mechanism or human outcome. It is evidence about an epothilone B manipulation and anesthetic response in rats, not direct validation of the specific modeled band.
HYP-01hypothesisInterpretation
Quantum activity in microtubules is a proposed explanation of consciousness and anesthetic action.
This is a research hypothesis, not a settled causal account. The 2025 review argues in favor of the broader proposal, but that review is an author's synthesis and does not independently validate the specific modeled 613 THz band.